nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—autistic disorder	0.509	0.699	CbGaD
Loperamide—OPRM1—autistic disorder	0.22	0.301	CbGaD
Loperamide—CACNA1A—cerebellar cortex—autistic disorder	0.0153	0.141	CbGeAlD
Loperamide—POMC—telencephalic ventricle—autistic disorder	0.00935	0.086	CbGeAlD
Loperamide—POMC—hindbrain—autistic disorder	0.00441	0.0406	CbGeAlD
Loperamide—CACNA1A—hindbrain—autistic disorder	0.00421	0.0387	CbGeAlD
Loperamide—OPRM1—telencephalic ventricle—autistic disorder	0.00352	0.0324	CbGeAlD
Loperamide—CALM2—pons—autistic disorder	0.0031	0.0285	CbGeAlD
Loperamide—CALM1—pons—autistic disorder	0.00309	0.0284	CbGeAlD
Loperamide—POMC—brainstem—autistic disorder	0.00253	0.0233	CbGeAlD
Loperamide—POMC—forebrain—autistic disorder	0.00244	0.0224	CbGeAlD
Loperamide—CACNA1A—brainstem—autistic disorder	0.00242	0.0222	CbGeAlD
Loperamide—CACNA1A—forebrain—autistic disorder	0.00233	0.0214	CbGeAlD
Loperamide—POMC—telencephalon—autistic disorder	0.00225	0.0206	CbGeAlD
Loperamide—CACNA1A—telencephalon—autistic disorder	0.00214	0.0197	CbGeAlD
Loperamide—POMC—digestive system—autistic disorder	0.00171	0.0158	CbGeAlD
Loperamide—POMC—head—autistic disorder	0.0014	0.0129	CbGeAlD
Loperamide—OPRD1—forebrain—autistic disorder	0.00135	0.0124	CbGeAlD
Loperamide—CACNA1A—head—autistic disorder	0.00133	0.0123	CbGeAlD
Loperamide—POMC—nervous system—autistic disorder	0.00133	0.0122	CbGeAlD
Loperamide—OPRK1—forebrain—autistic disorder	0.00129	0.0119	CbGeAlD
Loperamide—POMC—central nervous system—autistic disorder	0.00128	0.0117	CbGeAlD
Loperamide—CACNA1A—nervous system—autistic disorder	0.00127	0.0116	CbGeAlD
Loperamide—POMC—cerebellum—autistic disorder	0.00125	0.0115	CbGeAlD
Loperamide—OPRD1—telencephalon—autistic disorder	0.00124	0.0114	CbGeAlD
Loperamide—CACNA1A—central nervous system—autistic disorder	0.00122	0.0112	CbGeAlD
Loperamide—CALM2—hindbrain—autistic disorder	0.00121	0.0111	CbGeAlD
Loperamide—CALM1—hindbrain—autistic disorder	0.0012	0.011	CbGeAlD
Loperamide—CACNA1A—cerebellum—autistic disorder	0.00119	0.0109	CbGeAlD
Loperamide—CALM2—mouth—autistic disorder	0.00106	0.00972	CbGeAlD
Loperamide—CALM1—mouth—autistic disorder	0.00105	0.00968	CbGeAlD
Loperamide—POMC—brain—autistic disorder	0.00101	0.00931	CbGeAlD
Loperamide—CACNA1A—brain—autistic disorder	0.000967	0.00889	CbGeAlD
Loperamide—OPRM1—brainstem—autistic disorder	0.000952	0.00875	CbGeAlD
Loperamide—OPRM1—forebrain—autistic disorder	0.000919	0.00845	CbGeAlD
Loperamide—CALM3—eye—autistic disorder	0.000857	0.00788	CbGeAlD
Loperamide—OPRM1—telencephalon—autistic disorder	0.000845	0.00777	CbGeAlD
Loperamide—CALM3—telencephalon—autistic disorder	0.000781	0.00718	CbGeAlD
Loperamide—OPRD1—head—autistic disorder	0.000772	0.00709	CbGeAlD
Loperamide—OPRK1—head—autistic disorder	0.00074	0.0068	CbGeAlD
Loperamide—OPRD1—nervous system—autistic disorder	0.000732	0.00672	CbGeAlD
Loperamide—OPRD1—central nervous system—autistic disorder	0.000704	0.00647	CbGeAlD
Loperamide—Tamoxifen—DHCR7—autistic disorder	0.000703	0.128	CrCbGaD
Loperamide—OPRK1—nervous system—autistic disorder	0.000701	0.00645	CbGeAlD
Loperamide—CALM2—brainstem—autistic disorder	0.000691	0.00635	CbGeAlD
Loperamide—CALM1—brainstem—autistic disorder	0.000688	0.00632	CbGeAlD
Loperamide—Difenoxin—OPRM1—autistic disorder	0.000676	0.123	CrCbGaD
Loperamide—OPRK1—central nervous system—autistic disorder	0.000675	0.00621	CbGeAlD
Loperamide—CALM2—eye—autistic disorder	0.000673	0.00618	CbGeAlD
Loperamide—CALM1—eye—autistic disorder	0.00067	0.00616	CbGeAlD
Loperamide—CALM2—forebrain—autistic disorder	0.000667	0.00613	CbGeAlD
Loperamide—CYP2D6—hindbrain—autistic disorder	0.000666	0.00612	CbGeAlD
Loperamide—CALM1—forebrain—autistic disorder	0.000664	0.0061	CbGeAlD
Loperamide—OPRK1—cerebellum—autistic disorder	0.00066	0.00607	CbGeAlD
Loperamide—Anileridine—OPRM1—autistic disorder	0.000659	0.12	CrCbGaD
Loperamide—CALM2—telencephalon—autistic disorder	0.000613	0.00564	CbGeAlD
Loperamide—CALM1—telencephalon—autistic disorder	0.00061	0.00561	CbGeAlD
Loperamide—OPRD1—brain—autistic disorder	0.000559	0.00514	CbGeAlD
Loperamide—Methadyl Acetate—OPRM1—autistic disorder	0.000551	0.1	CrCbGaD
Loperamide—OPRK1—brain—autistic disorder	0.000536	0.00493	CbGeAlD
Loperamide—OPRM1—head—autistic disorder	0.000526	0.00484	CbGeAlD
Loperamide—OPRM1—nervous system—autistic disorder	0.000499	0.00459	CbGeAlD
Loperamide—OPRM1—central nervous system—autistic disorder	0.00048	0.00442	CbGeAlD
Loperamide—Diphenoxylate—OPRM1—autistic disorder	0.000476	0.0866	CrCbGaD
Loperamide—CALM2—digestive system—autistic disorder	0.000468	0.0043	CbGeAlD
Loperamide—CALM1—digestive system—autistic disorder	0.000466	0.00428	CbGeAlD
Loperamide—CALM3—cerebellum—autistic disorder	0.000434	0.00399	CbGeAlD
Loperamide—CALM2—head—autistic disorder	0.000382	0.00351	CbGeAlD
Loperamide—CYP2D6—brainstem—autistic disorder	0.000382	0.00351	CbGeAlD
Loperamide—OPRM1—brain—autistic disorder	0.000381	0.00351	CbGeAlD
Loperamide—CALM1—head—autistic disorder	0.00038	0.00349	CbGeAlD
Loperamide—CYP2D6—forebrain—autistic disorder	0.000368	0.00339	CbGeAlD
Loperamide—CALM2—nervous system—autistic disorder	0.000362	0.00333	CbGeAlD
Loperamide—CALM1—nervous system—autistic disorder	0.00036	0.00331	CbGeAlD
Loperamide—CALM3—brain—autistic disorder	0.000352	0.00324	CbGeAlD
Loperamide—CALM2—central nervous system—autistic disorder	0.000349	0.0032	CbGeAlD
Loperamide—CYP2B6—digestive system—autistic disorder	0.000348	0.0032	CbGeAlD
Loperamide—CALM1—central nervous system—autistic disorder	0.000347	0.00319	CbGeAlD
Loperamide—CALM2—cerebellum—autistic disorder	0.000341	0.00313	CbGeAlD
Loperamide—CALM1—cerebellum—autistic disorder	0.000339	0.00312	CbGeAlD
Loperamide—CYP2D6—telencephalon—autistic disorder	0.000339	0.00311	CbGeAlD
Loperamide—Haloperidol—HTR1D—autistic disorder	0.000297	0.054	CrCbGaD
Loperamide—CYP2B6—head—autistic disorder	0.000284	0.00261	CbGeAlD
Loperamide—CALM2—brain—autistic disorder	0.000277	0.00254	CbGeAlD
Loperamide—CALM1—brain—autistic disorder	0.000275	0.00253	CbGeAlD
Loperamide—CYP2B6—nervous system—autistic disorder	0.000269	0.00247	CbGeAlD
Loperamide—ABCB1—forebrain—autistic disorder	0.000265	0.00244	CbGeAlD
Loperamide—CYP3A4—digestive system—autistic disorder	0.000263	0.00242	CbGeAlD
Loperamide—CYP2B6—central nervous system—autistic disorder	0.000259	0.00238	CbGeAlD
Loperamide—CYP2D6—digestive system—autistic disorder	0.000259	0.00238	CbGeAlD
Loperamide—ABCB1—telencephalon—autistic disorder	0.000244	0.00224	CbGeAlD
Loperamide—Levomethadyl Acetate—OPRM1—autistic disorder	0.00024	0.0436	CrCbGaD
Loperamide—CYP2C8—brain—autistic disorder	0.000229	0.00211	CbGeAlD
Loperamide—CYP2D6—head—autistic disorder	0.000211	0.00194	CbGeAlD
Loperamide—Dextropropoxyphene—OPRM1—autistic disorder	0.000207	0.0377	CrCbGaD
Loperamide—CYP2B6—brain—autistic disorder	0.000206	0.00189	CbGeAlD
Loperamide—Fentanyl—OPRM1—autistic disorder	0.000205	0.0373	CrCbGaD
Loperamide—CYP3A4—nervous system—autistic disorder	0.000203	0.00187	CbGeAlD
Loperamide—CYP2D6—nervous system—autistic disorder	0.0002	0.00184	CbGeAlD
Loperamide—CYP3A4—central nervous system—autistic disorder	0.000196	0.0018	CbGeAlD
Loperamide—Methadone—HTR3A—autistic disorder	0.000196	0.0356	CrCbGaD
Loperamide—CYP2D6—central nervous system—autistic disorder	0.000193	0.00177	CbGeAlD
Loperamide—CYP2D6—cerebellum—autistic disorder	0.000188	0.00173	CbGeAlD
Loperamide—ABCB1—digestive system—autistic disorder	0.000186	0.00171	CbGeAlD
Loperamide—Haloperidol—HTR1B—autistic disorder	0.000176	0.032	CrCbGaD
Loperamide—Haloperidol—DRD3—autistic disorder	0.000171	0.0311	CrCbGaD
Loperamide—Levomethadyl Acetate—CYP19A1—autistic disorder	0.00017	0.0309	CrCbGaD
Loperamide—Clotrimazole—CYP19A1—autistic disorder	0.00017	0.0309	CrCbGaD
Loperamide—Haloperidol—DRD1—autistic disorder	0.000168	0.0305	CrCbGaD
Loperamide—CYP2D6—brain—autistic disorder	0.000153	0.00141	CbGeAlD
Loperamide—ABCB1—head—autistic disorder	0.000152	0.0014	CbGeAlD
Loperamide—ABCB1—nervous system—autistic disorder	0.000144	0.00132	CbGeAlD
Loperamide—Methadone—OPRM1—autistic disorder	0.000141	0.0256	CrCbGaD
Loperamide—ABCB1—central nervous system—autistic disorder	0.000139	0.00127	CbGeAlD
Loperamide—ABCB1—cerebellum—autistic disorder	0.000135	0.00124	CbGeAlD
Loperamide—ABCB1—brain—autistic disorder	0.00011	0.00101	CbGeAlD
Loperamide—Tamoxifen—CYP19A1—autistic disorder	0.0001	0.0182	CrCbGaD
Loperamide—Methadone—CYP19A1—autistic disorder	9.95e-05	0.0181	CrCbGaD
Loperamide—Haloperidol—HTR2A—autistic disorder	9.15e-05	0.0166	CrCbGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—autistic disorder	4.52e-06	2.88e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTP1—autistic disorder	4.51e-06	2.88e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ADRB2—autistic disorder	4.51e-06	2.88e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MAOA—autistic disorder	4.5e-06	2.87e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GPX1—autistic disorder	4.41e-06	2.82e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GPX1—autistic disorder	4.41e-06	2.82e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CAT—autistic disorder	4.39e-06	2.8e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IGF1—autistic disorder	4.38e-06	2.79e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGF—autistic disorder	4.38e-06	2.79e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGF—autistic disorder	4.38e-06	2.79e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADRB2—autistic disorder	4.36e-06	2.78e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADRB2—autistic disorder	4.36e-06	2.78e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—autistic disorder	4.36e-06	2.78e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—MAPK1—autistic disorder	4.36e-06	2.78e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—MTHFR—autistic disorder	4.33e-06	2.76e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MAOB—autistic disorder	4.32e-06	2.75e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PTEN—autistic disorder	4.27e-06	2.72e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CYP19A1—autistic disorder	4.25e-06	2.71e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AVP—autistic disorder	4.24e-06	2.7e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—MAPK1—autistic disorder	4.23e-06	2.7e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—APC—autistic disorder	4.22e-06	2.69e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—autistic disorder	4.22e-06	2.69e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—autistic disorder	4.22e-06	2.69e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF2—autistic disorder	4.22e-06	2.69e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—MTHFR—autistic disorder	4.21e-06	2.69e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—EGF—autistic disorder	4.18e-06	2.66e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SERPINE1—autistic disorder	4.16e-06	2.65e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PLA2G4A—autistic disorder	4.15e-06	2.64e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GSTM1—autistic disorder	4.15e-06	2.64e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HRAS—autistic disorder	4.14e-06	2.64e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AVP—autistic disorder	4.1e-06	2.61e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AVP—autistic disorder	4.1e-06	2.61e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—MAPK1—autistic disorder	4.09e-06	2.61e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—MAPK1—autistic disorder	4.09e-06	2.61e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—APC—autistic disorder	4.09e-06	2.61e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—APC—autistic disorder	4.09e-06	2.61e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF2—autistic disorder	4.08e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF2—autistic disorder	4.08e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—MTHFR—autistic disorder	4.07e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—MTHFR—autistic disorder	4.07e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—EGF—autistic disorder	4.04e-06	2.58e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—EGF—autistic disorder	4.04e-06	2.58e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—autistic disorder	4.03e-06	2.57e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TPH2—autistic disorder	4.02e-06	2.56e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CYP19A1—autistic disorder	4e-06	2.55e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PLA2G4A—autistic disorder	3.98e-06	2.54e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL2—autistic disorder	3.98e-06	2.54e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GPX1—autistic disorder	3.97e-06	2.53e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—autistic disorder	3.96e-06	2.53e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DPYD—autistic disorder	3.95e-06	2.52e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—COMT—autistic disorder	3.95e-06	2.52e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTP1—autistic disorder	3.93e-06	2.51e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MAOA—autistic disorder	3.92e-06	2.5e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—autistic disorder	3.92e-06	2.5e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MEF2C—autistic disorder	3.88e-06	2.47e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PLA2G4A—autistic disorder	3.85e-06	2.46e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PLA2G4A—autistic disorder	3.85e-06	2.46e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAT—autistic disorder	3.82e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—autistic disorder	3.79e-06	2.42e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—autistic disorder	3.79e-06	2.42e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ITGB3—autistic disorder	3.78e-06	2.41e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—HRAS—autistic disorder	3.77e-06	2.41e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MEF2C—autistic disorder	3.75e-06	2.39e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MEF2C—autistic disorder	3.75e-06	2.39e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PTEN—autistic disorder	3.74e-06	2.39e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—COMT—autistic disorder	3.72e-06	2.37e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTP1—autistic disorder	3.7e-06	2.36e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MAOA—autistic disorder	3.69e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—SERPINE1—autistic disorder	3.67e-06	2.34e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CACNA1C—autistic disorder	3.67e-06	2.34e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—MTHFR—autistic disorder	3.66e-06	2.34e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—BCL2—autistic disorder	3.66e-06	2.33e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ITGB3—autistic disorder	3.65e-06	2.33e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ITGB3—autistic disorder	3.65e-06	2.33e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—HRAS—autistic disorder	3.65e-06	2.33e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—HRAS—autistic disorder	3.65e-06	2.33e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3CG—autistic disorder	3.64e-06	2.32e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IFNG—autistic disorder	3.62e-06	2.31e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PLA2G4A—autistic disorder	3.61e-06	2.3e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GSTM1—autistic disorder	3.61e-06	2.3e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAT—autistic disorder	3.6e-06	2.3e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—SERPINE1—autistic disorder	3.55e-06	2.27e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—SERPINE1—autistic disorder	3.55e-06	2.27e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3CG—autistic disorder	3.54e-06	2.26e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—BCL2—autistic disorder	3.54e-06	2.26e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—BCL2—autistic disorder	3.54e-06	2.26e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR2A—autistic disorder	3.53e-06	2.25e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL2—autistic disorder	3.52e-06	2.25e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IFNG—autistic disorder	3.51e-06	2.24e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IFNG—autistic disorder	3.51e-06	2.24e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HRAS—autistic disorder	3.5e-06	2.23e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MAPK1—autistic disorder	3.47e-06	2.21e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—POMC—autistic disorder	3.46e-06	2.21e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GPX1—autistic disorder	3.46e-06	2.21e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3CG—autistic disorder	3.42e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3CG—autistic disorder	3.42e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR2A—autistic disorder	3.41e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR2A—autistic disorder	3.41e-06	2.18e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—autistic disorder	3.41e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL2—autistic disorder	3.41e-06	2.17e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL2—autistic disorder	3.41e-06	2.17e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PLA2G4A—autistic disorder	3.4e-06	2.17e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GSTM1—autistic disorder	3.4e-06	2.17e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—HRAS—autistic disorder	3.4e-06	2.17e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—POMC—autistic disorder	3.37e-06	2.15e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL2—autistic disorder	3.36e-06	2.15e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TSC2—autistic disorder	3.35e-06	2.14e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—autistic disorder	3.35e-06	2.13e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—DHFR—autistic disorder	3.34e-06	2.13e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—HRAS—autistic disorder	3.28e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—HRAS—autistic disorder	3.28e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—LEP—autistic disorder	3.28e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—autistic disorder	3.28e-06	2.09e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HRAS—autistic disorder	3.26e-06	2.08e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GPX1—autistic disorder	3.26e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—POMC—autistic disorder	3.26e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—POMC—autistic disorder	3.26e-06	2.08e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—autistic disorder	3.25e-06	2.07e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TSC2—autistic disorder	3.24e-06	2.07e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TSC2—autistic disorder	3.24e-06	2.07e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL2—autistic disorder	3.22e-06	2.05e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—autistic disorder	3.21e-06	2.05e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—MTHFR—autistic disorder	3.19e-06	2.04e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—LEP—autistic disorder	3.17e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—LEP—autistic disorder	3.17e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—autistic disorder	3.17e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—autistic disorder	3.17e-06	2.02e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PTEN—autistic disorder	3.16e-06	2.02e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HRAS—autistic disorder	3.15e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HRAS—autistic disorder	3.15e-06	2.01e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—autistic disorder	3.14e-06	2e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—autistic disorder	3.14e-06	2e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL2—autistic disorder	3.12e-06	1.99e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL2—autistic disorder	3.12e-06	1.99e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—autistic disorder	3.1e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—autistic disorder	3.1e-06	1.98e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PRKCB—autistic disorder	3.09e-06	1.97e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3CG—autistic disorder	3.08e-06	1.96e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MAPK1—autistic disorder	3.04e-06	1.94e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—PTEN—autistic disorder	3.03e-06	1.93e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—MTHFR—autistic disorder	3.01e-06	1.92e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRKCB—autistic disorder	2.99e-06	1.91e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRKCB—autistic disorder	2.99e-06	1.91e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—autistic disorder	2.97e-06	1.9e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APC—autistic disorder	2.96e-06	1.89e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PIK3CG—autistic disorder	2.96e-06	1.89e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—PTEN—autistic disorder	2.93e-06	1.87e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—PTEN—autistic disorder	2.93e-06	1.87e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—POMC—autistic disorder	2.93e-06	1.87e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGF—autistic disorder	2.92e-06	1.87e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PIK3CG—autistic disorder	2.86e-06	1.83e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APC—autistic disorder	2.86e-06	1.83e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PIK3CG—autistic disorder	2.86e-06	1.83e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APC—autistic disorder	2.86e-06	1.83e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGF—autistic disorder	2.83e-06	1.8e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGF—autistic disorder	2.83e-06	1.8e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—POMC—autistic disorder	2.82e-06	1.8e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—autistic disorder	2.8e-06	1.79e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PTEN—autistic disorder	2.8e-06	1.78e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRAS—autistic disorder	2.79e-06	1.78e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—autistic disorder	2.76e-06	1.76e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—POMC—autistic disorder	2.72e-06	1.74e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—POMC—autistic disorder	2.72e-06	1.74e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—autistic disorder	2.71e-06	1.73e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTEN—autistic disorder	2.71e-06	1.73e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTEN—autistic disorder	2.71e-06	1.73e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—MAPK1—autistic disorder	2.7e-06	1.72e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—autistic disorder	2.69e-06	1.71e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3CG—autistic disorder	2.68e-06	1.71e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—autistic disorder	2.67e-06	1.7e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—autistic disorder	2.62e-06	1.67e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—autistic disorder	2.62e-06	1.67e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP19A1—autistic disorder	2.62e-06	1.67e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—MAPK1—autistic disorder	2.61e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—MAPK1—autistic disorder	2.61e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—autistic disorder	2.6e-06	1.66e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—autistic disorder	2.6e-06	1.66e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MAPK1—autistic disorder	2.57e-06	1.64e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SERPINE1—autistic disorder	2.57e-06	1.64e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—POMC—autistic disorder	2.55e-06	1.63e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3CG—autistic disorder	2.53e-06	1.61e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SERPINE1—autistic disorder	2.49e-06	1.59e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SERPINE1—autistic disorder	2.49e-06	1.59e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—MAPK1—autistic disorder	2.46e-06	1.57e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRAS—autistic disorder	2.44e-06	1.56e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—COMT—autistic disorder	2.43e-06	1.55e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTP1—autistic disorder	2.42e-06	1.54e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MAOA—autistic disorder	2.42e-06	1.54e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTEN—autistic disorder	2.41e-06	1.54e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—POMC—autistic disorder	2.41e-06	1.53e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—MAPK1—autistic disorder	2.38e-06	1.52e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—MAPK1—autistic disorder	2.38e-06	1.52e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAT—autistic disorder	2.36e-06	1.5e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTEN—autistic disorder	2.34e-06	1.49e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—autistic disorder	2.34e-06	1.49e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—autistic disorder	2.34e-06	1.49e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—MAPK1—autistic disorder	2.27e-06	1.45e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTEN—autistic disorder	2.27e-06	1.45e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTEN—autistic disorder	2.27e-06	1.45e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLA2G4A—autistic disorder	2.22e-06	1.42e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GSTM1—autistic disorder	2.22e-06	1.42e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—MAPK1—autistic disorder	2.2e-06	1.4e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—MAPK1—autistic disorder	2.2e-06	1.4e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRAS—autistic disorder	2.16e-06	1.38e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GPX1—autistic disorder	2.13e-06	1.36e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRAS—autistic disorder	2.09e-06	1.34e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRAS—autistic disorder	2.09e-06	1.34e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2—autistic disorder	2.08e-06	1.33e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—autistic disorder	2.07e-06	1.32e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRAS—autistic disorder	2.07e-06	1.32e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTEN—autistic disorder	2.04e-06	1.3e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—autistic disorder	2.04e-06	1.3e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2—autistic disorder	2.01e-06	1.28e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2—autistic disorder	2.01e-06	1.28e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—autistic disorder	2e-06	1.28e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—autistic disorder	2e-06	1.28e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—HRAS—autistic disorder	1.98e-06	1.26e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—autistic disorder	1.98e-06	1.26e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—MTHFR—autistic disorder	1.97e-06	1.25e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PTEN—autistic disorder	1.96e-06	1.25e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—autistic disorder	1.92e-06	1.22e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—HRAS—autistic disorder	1.91e-06	1.22e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—HRAS—autistic disorder	1.91e-06	1.22e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PTEN—autistic disorder	1.89e-06	1.21e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PTEN—autistic disorder	1.89e-06	1.21e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—autistic disorder	1.89e-06	1.21e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—autistic disorder	1.83e-06	1.17e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—autistic disorder	1.83e-06	1.17e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—autistic disorder	1.83e-06	1.17e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—HRAS—autistic disorder	1.83e-06	1.16e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTEN—autistic disorder	1.78e-06	1.13e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—HRAS—autistic disorder	1.77e-06	1.13e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—HRAS—autistic disorder	1.77e-06	1.13e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—autistic disorder	1.75e-06	1.11e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—autistic disorder	1.69e-06	1.08e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—autistic disorder	1.69e-06	1.08e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTEN—autistic disorder	1.67e-06	1.07e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.65e-06	1.05e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MAPK1—autistic disorder	1.59e-06	1.02e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—POMC—autistic disorder	1.57e-06	1e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MAPK1—autistic disorder	1.54e-06	9.83e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAPK1—autistic disorder	1.54e-06	9.83e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRAS—autistic disorder	1.28e-06	8.15e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—autistic disorder	1.25e-06	8e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRAS—autistic disorder	1.24e-06	7.89e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRAS—autistic disorder	1.24e-06	7.89e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—autistic disorder	1.22e-06	7.8e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—autistic disorder	1.18e-06	7.55e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—autistic disorder	1.18e-06	7.55e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTEN—autistic disorder	1.09e-06	6.98e-06	CbGpPWpGaD
